Florida Senate - 2015                        COMMITTEE AMENDMENT
       Bill No. CS for CS for SB 614
       
       
       
       
       
       
                                Ì149458RÎ149458                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  04/20/2015           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Rules (Gaetz) recommended the following:
       
    1         Senate Amendment to Amendment (395678) (with title
    2  amendment)
    3  
    4         Before line 5
    5  insert:
    6         Section 1. Paragraph (c) of subsection (2) of section
    7  409.967, Florida Statutes, is amended to read:
    8         409.967 Managed care plan accountability.—
    9         (2) The agency shall establish such contract requirements
   10  as are necessary for the operation of the statewide managed care
   11  program. In addition to any other provisions the agency may deem
   12  necessary, the contract must require:
   13         (c) Access.—
   14         1. The agency shall establish specific standards for the
   15  number, type, and regional distribution of providers in managed
   16  care plan networks to ensure access to care for both adults and
   17  children. Each plan must maintain a regionwide network of
   18  providers in sufficient numbers to meet the access standards for
   19  specific medical services for all recipients enrolled in the
   20  plan. The exclusive use of mail-order pharmacies may not be
   21  sufficient to meet network access standards. Consistent with the
   22  standards established by the agency, provider networks may
   23  include providers located outside the region. A plan may
   24  contract with a new hospital facility before the date the
   25  hospital becomes operational if the hospital has commenced
   26  construction, will be licensed and operational by January 1,
   27  2013, and a final order has issued in any civil or
   28  administrative challenge. Each plan shall establish and maintain
   29  an accurate and complete electronic database of contracted
   30  providers, including information about licensure or
   31  registration, locations and hours of operation, specialty
   32  credentials and other certifications, specific performance
   33  indicators, and such other information as the agency deems
   34  necessary. The database must be available online to both the
   35  agency and the public and have the capability to compare the
   36  availability of providers to network adequacy standards and to
   37  accept and display feedback from each provider’s patients. Each
   38  plan shall submit quarterly reports to the agency identifying
   39  the number of enrollees assigned to each primary care provider.
   40         2. Each managed care plan must publish any prescribed drug
   41  formulary or preferred drug list on the plan’s website in a
   42  manner that is accessible to and searchable by enrollees and
   43  providers. The plan must update the list within 24 hours after
   44  making a change. Each plan must ensure that the prior
   45  authorization process for prescribed drugs is readily accessible
   46  to health care providers, including posting appropriate contact
   47  information on its website and providing timely responses to
   48  providers. For Medicaid recipients diagnosed with hemophilia who
   49  have been prescribed anti-hemophilic-factor replacement
   50  products, the agency shall provide for those products and
   51  hemophilia overlay services through the agency’s hemophilia
   52  disease management program.
   53         3. Managed care plans, and their fiscal agents or
   54  intermediaries, must accept prior authorization requests for any
   55  service electronically.
   56         4. Managed care plans serving children in the care and
   57  custody of the Department of Children and Families must maintain
   58  complete medical, dental, and behavioral health encounter
   59  information and participate in making such information available
   60  to the department or the applicable contracted community-based
   61  care lead agency for use in providing comprehensive and
   62  coordinated case management. The agency and the department shall
   63  establish an interagency agreement to provide guidance for the
   64  format, confidentiality, recipient, scope, and method of
   65  information to be made available and the deadlines for
   66  submission of the data. The scope of information available to
   67  the department shall be the data that managed care plans are
   68  required to submit to the agency. The agency shall determine the
   69  plan’s compliance with standards for access to medical, dental,
   70  and behavioral health services; the use of medications; and
   71  followup on all medically necessary services recommended as a
   72  result of early and periodic screening, diagnosis, and
   73  treatment.
   74         5. If medication for the treatment of a medical condition
   75  is restricted for use by a managed care plan through a step
   76  therapy or fail-first protocol, the prescribing provider shall
   77  have access to a clear and convenient process to request an
   78  override of such restriction from the managed care plan. The
   79  managed care plan shall grant an override of the protocol within
   80  24 hours under the following circumstances:
   81         a. The prescribing provider determines, based on sound
   82  clinical evidence, that the preferred treatment required under
   83  the step-therapy or fail-first protocol has been ineffective in
   84  the treatment of the enrollee’s disease or medical condition; or
   85         b. The prescribing provider believes, based on sound
   86  clinical evidence or medical and scientific evidence, that the
   87  preferred treatment required under the step-therapy or fail
   88  first protocol:
   89         (I) Is expected to, or is likely to, be ineffective given
   90  the known relevant physical or mental characteristics and
   91  medical history of the enrollee and the known characteristics of
   92  the drug regimen; or
   93         (II) Will cause, or is likely to cause, an adverse reaction
   94  or other physical harm to the enrollee.
   95         6. If the prescribing provider allows the enrollee to enter
   96  the step-therapy or fail-first protocol recommended by the
   97  managed care plan, the duration of the step-therapy or fail
   98  first protocol may not exceed a period deemed appropriate by the
   99  prescribing provider. If the prescribing provider deems the
  100  treatment clinically ineffective, the enrollee is entitled to
  101  receive the recommended course of therapy without requiring the
  102  prescribing provider to seek approval for an override of the
  103  step-therapy or fail-first protocol.
  104         Section 2. Section 627.42392, Florida Statutes, is created
  105  to read:
  106         627.42392 Prior Authorization.—
  107         (1)As used in this section, the term “health insurer”
  108  means an authorized insurer offering health insurance as defined
  109  in s. 624.603, a managed care plan as defined in s. 409.901(13),
  110  or a health maintenance organization as defined in s.
  111  641.19(12).
  112         (2) Notwithstanding any other provision of law, in order to
  113  establish uniformity in the submission of prior authorization
  114  forms on or after January 1, 2016, a health insurer, or a
  115  pharmacy benefits manager on behalf of the health insurer, which
  116  does not utilize an online prior authorization form for its
  117  contracted providers shall use only the prior authorization form
  118  that has been approved by the Financial Services Commission to
  119  obtain a prior authorization for a medical procedure, course of
  120  treatment, or prescription drug benefit. Such form may not
  121  exceed two pages in length, excluding any instructions or
  122  guiding documentation.
  123         (3) The Financial Services Commission shall adopt by rule
  124  guidelines for prior authorization forms which ensure the
  125  general uniformity of such forms.
  126         Section 3. Subsection (11) of section 627.6131, Florida
  127  Statutes, is amended to read:
  128         627.6131 Payment of claims.—
  129         (11) A health insurer may not retroactively deny a claim
  130  because of insured ineligibility:
  131         (a)At any time, if the health insurer verified the
  132  eligibility of an insured at the time of treatment and provided
  133  an authorization number.
  134         (b) More than 1 year after the date of payment of the
  135  claim.
  136         Section 4. Section 627.6466, Florida Statutes, is created
  137  to read:
  138         627.6466 Fail-first protocols.—If medication for the
  139  treatment of a medical condition is restricted for use by an
  140  insurer through a step-therapy or fail-first protocol, the
  141  prescribing provider shall have access to a clear and convenient
  142  process to request an override of such restriction from the
  143  insurer. The insurer shall grant an override of the protocol
  144  within 24 hours under the following circumstances:
  145         (1) The prescribing provider determines, based on sound
  146  clinical evidence, that the preferred treatment required under
  147  the step-therapy or fail-first protocol has been ineffective in
  148  the treatment of the insured’s disease or medical condition; or
  149         (2)The prescribing provider believes, based on sound
  150  clinical evidence or medical and scientific evidence, that the
  151  preferred treatment required under the step-therapy or fail
  152  first protocol:
  153         (a) Is expected to, or is likely to, be ineffective given
  154  the known relevant physical or mental characteristics and
  155  medical history of the insured and the known characteristics of
  156  the drug regimen; or
  157         (b) Will cause, or is likely to cause, an adverse reaction
  158  or other physical harm to the insured.
  159         (3) If the prescribing provider allows the insured to enter
  160  the step-therapy or fail-first protocol recommended by the
  161  health insurer, the duration of the step-therapy or fail-first
  162  protocol may not exceed a period deemed appropriate by the
  163  provider. If the prescribing provider deems the treatment
  164  clinically ineffective, the insured is entitled to receive the
  165  recommended course of therapy without requiring the prescribing
  166  provider to seek approval for an override of the step-therapy or
  167  fail-first protocol.
  168         Section 5. Subsection (10) of section 641.3155, Florida
  169  Statutes, is amended to read:
  170         641.3155 Prompt payment of claims.—
  171         (10) A health maintenance organization may not
  172  retroactively deny a claim because of subscriber ineligibility:
  173         (a)At any time, if the health maintenance organization
  174  verified the eligibility of an insured at the time of treatment
  175  and provided an authorization number.
  176         (b) More than 1 year after the date of payment of the
  177  claim.
  178         Section 6. Section 641.393, Florida Statutes, is created to
  179  read:
  180         641.393Fail-first protocols.—If medication for the
  181  treatment of a medical condition is restricted for use by a
  182  health maintenance organization through a step-therapy or fail
  183  first protocol, the prescribing provider shall have access to a
  184  clear and convenient process to request an override of such
  185  restriction from the organization. The health maintenance
  186  organization shall grant an override of the protocol within 24
  187  hours under the following circumstances:
  188         (1) The prescribing provider determines, based on sound
  189  clinical evidence, that the preferred treatment required under
  190  step-therapy or fail-first protocol has been ineffective in the
  191  treatment of the subscriber’s disease or medical condition; or
  192         (2) The prescribing provider believes, based on sound
  193  clinical evidence or medical and scientific evidence, that the
  194  preferred treatment required under the step-therapy or fail
  195  first protocol:
  196         (a) Is expected to, or is likely to, be ineffective given
  197  the known relevant physical or mental characteristics and
  198  medical history of the subscriber and the known characteristics
  199  of the drug regimen; or
  200         (b) Will cause, or is likely to cause, an adverse reaction
  201  or other physical harm to the subscriber.
  202         (3) If the prescribing provider allows the subscriber to
  203  enter the step-therapy or fail-first protocol recommended by the
  204  health maintenance organization, the duration of the step
  205  therapy or fail-first protocol may not exceed a period deemed
  206  appropriate by the provider. If the prescribing provider deems
  207  the treatment clinically ineffective, the subscriber is entitled
  208  to receive the recommended course of therapy without requiring
  209  the prescribing provider to seek approval for an override of the
  210  step-therapy or fail-first protocol.
  211  
  212  ================= T I T L E  A M E N D M E N T ================
  213  And the title is amended as follows:
  214         Delete lines 882 - 884
  215  and insert:
  216         An act relating to health care; amending s. 409.967,
  217         F.S.; requiring a Medicaid managed care plan to allow
  218         a prescribing provider to request an override of a
  219         restriction on the use of medication imposed through a
  220         step-therapy or fail-first protocol; requiring the
  221         plan to grant such override within a specified
  222         timeframe under certain circumstances; prohibiting the
  223         duration of a step-therapy or fail-first protocol from
  224         exceeding the time period specified by the prescribing
  225         provider; providing that an override is not required
  226         under certain circumstances; creating s. 627.42392,
  227         F.S.; defining the term “health insurer”; providing
  228         that certain health insurers shall use only a prior
  229         authorization form approved by the Financial Services
  230         Commission; specifying requirements to be followed by
  231         the commission in reviewing such forms; requiring the
  232         commission to adopt certain rules relating to such
  233         forms; amending s. 627.6131, F.S.; prohibiting a
  234         health insurer from retroactively denying a claim
  235         under specified circumstances; creating s. 627.6466,
  236         F.S.; requiring an insurer to allow a prescribing
  237         provider to request an override of a restriction on
  238         the use of medication imposed through a step-therapy
  239         or fail-first protocol; requiring the insurer to grant
  240         such override within a specified timeframe under
  241         certain circumstances; prohibiting the duration of a
  242         step-therapy or fail-first protocol from exceeding the
  243         time period specified by the prescribing provider;
  244         providing that an override is not required under
  245         certain circumstances; amending s. 641.3155, F.S.;
  246         prohibiting a health maintenance organization from
  247         retroactively denying a claim under specified
  248         circumstances; creating s. 641.393, F.S.; requiring a
  249         health maintenance organization to allow a prescribing
  250         provider to request an override of a restriction on
  251         the use of medication imposed through a step-therapy
  252         or fail-first protocol; requiring the health
  253         maintenance organization to grant such override within
  254         a specified timeframe under certain circumstances;
  255         prohibiting the duration of a step-therapy or fail
  256         first protocol from exceeding the time period
  257         specified by the prescribing provider; providing that
  258         an override is not required under certain
  259         circumstances; amending s. 110.12315, F.S.; expanding
  260         the